SCHEMBL17925873

SCHEMBL17925873

CC1Cn2nccc2CN1C(N)=O

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 3/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ RIPK1 Q13546 3/20 0.32
▸ PDK1 Q15118 1/20 0.30
▸ PDK2 Q15119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28556462 0.86 GRM5 (0.35) GRM5NPC1RIPK1
SCHEMBL28361295 0.79 — —
SCHEMBL29415570 0.76 MAPT (0.33) GRM5
SCHEMBL17926162 0.68 MYT1 (0.42) GRM5RIPK1
SCHEMBL8362604 0.68 — —
SCHEMBL28883948 0.65 NR1H2 (0.39) GRM5
SCHEMBL31451499 0.65 MEN1 (0.41) —
SCHEMBL18338645 0.64 — —
SCHEMBL31362597 0.61 NPC1 (0.33) NPC1
SCHEMBL30519647 0.61 RIPK1 (0.51) GRM5NPC1RIPK1PDK1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3245206-A1 PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES F. Hoffmann-La Roche AG (CH) 2017-11-22 — — EP claimed
WO-2016113273-A1 PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2016-07-21 — — WO claimed
EP-3245206-A1 PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES F. Hoffmann-La Roche AG (CH) 2017-11-22 — — EP disclosed
WO-2016113273-A1 PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2016-07-21 — — WO disclosed
Send feedback